Assesment of Markers of Endothelial Dysfunction and Myocardial Stress in Patients with Hypertrophic Cardyomyopathy
Aim. To study the level of serum biomarkers of endothelial dysfunction and myocardial stress in patients with various types of hypertrophic cardiomyopathy (HCM).Material and Methods. 48 patients with hypertrophic cardiomyopathy (27 men and 21 women) were examined, the mean age was 54±13 years. The p...
Saved in:
| Main Authors: | F. M. Bogatyreva, V. Yu. Kaplunova, M. V. Kozhevnikova, G. A. Shakaryants, D. A. Yatsenko, А. V. Emelianov, A. S. Lishuta, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2021-07-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2498 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypertrophic Cardiomyopathy and Connective Tissue Dysplasia Syndrome: Comorbidity Variants
by: Yu. N. Belenkov, et al.
Published: (2016-11-01) -
CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
by: E. V. Privalova, et al.
Published: (2013-02-01) -
AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2009-06-01) -
RARE CASES OF HYPERTROPHIC CARDIOMYOPATHY: VARIANTS AND CLINICAL OBSERVATIONS
by: V. Yu. Zimina, et al.
Published: (2015-09-01) -
Development of predictive models for differential diagnosis of hypertrophic cardiomyopathy
by: V. V. Zaitsev, et al.
Published: (2024-12-01)